News
A new research paper was published in Volume 16 of Oncotarget on July 9, 2025, titled "A novel anti-human CD25 mAb with ...
12h
The Brighterside of News on MSNAntibody spray breakthrough could prevent hay fever and asthmaA new scientific discovery is offering a promising breakthrough for people struggling with hay fever and asthma triggered by pollen. Scientists have found a way to stop allergic reactions caused by ...
Monoclonal antibodies (mAbs) are laboratory-produced molecules derived from the B cells of an infected host. They are being investigated as a potential therapy for coronavirus disease 2019 (COVID‐19).
Circular dichroism and fluorescence were used to create a platform for monitoring changes in monoclonal antibodies.
Titer tests are what's used "to help you determine if you currently have immunity to certain diseases due to past infection or vaccination,” says Dr. Alison Mitzner, a New York board-certified ...
A new microchip invented by Scripps Research scientists can reveal how a person's antibodies interact with viruses—using just ...
Understanding Rheumatoid Arthritis Lab Tests And Results Rheumatoid arthritis (RA) is an autoimmune disease that causes joint inflammation, pain, and potential damage.
Possible explanations include the following: 1) a laboratory error—antibody titers are reagent- and operator-dependent, so the same blood sample may reveal different titers when run by different ...
SHANGHAI & CAMBRIDGE, Mass., June 13, 2025--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced new data from its preclinical study of ZL-1503, the Company’s promising IL-13/IL-31R ...
Zai Lab Presents New Preclinical Data for ZL-1503, an IL-13/IL-31R Bispecific Antibody for the Treatment of Atopic Dermatitis, at EAACI Congress 2025 ...
Detection of HLA-I antibodies by multiplex assay based on microspheres using the luminex platform The detection test for anti-HLA class I antibodies was performed using the Lifecodes LifeScreen Deluxe ...
Zai Lab Receives U.S. FDA Fast Track Designation for ZL-1310, a DLL3-Targeted Antibody-Drug Conjugate, for Treatment of Extensive-Stage Small Cell Lung Cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results